CV Sciences, Inc. (CVSI)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Annual

0 20M 40M 60M FY16: 11.1M FY17: 20.7M FY18: 48.2M FY19: 53.7M FY20: 24.4M FY21: 20M FY22: 16.2M FY23: 16M FY24: 15.7M FY25: 13.8M FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Gross Profit Annual

0 15M 30M 45M FY16: 7M FY17: 14.5M FY18: 33.9M FY19: 35.1M FY20: 11M FY21: 8.6M FY22: 5.5M FY23: 7.1M FY24: 7.2M FY25: 6.8M FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Operating Income Annual

-24M -16M -8M 0 8M 16M 24M FY16: -13.1M FY17: -4.9M FY18: 10.2M FY19: -17.2M FY20: -22.6M FY21: -18.4M FY22: -6.8M FY23: 3.4M FY24: -2.2M FY25: -470K FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Net Income Annual

-24M -16M -8M 0 8M 16M 24M FY16: -14.1M FY17: -4.9M FY18: 10M FY19: -16.6M FY20: -22.3M FY21: -15.6M FY22: -8.2M FY23: 3.1M FY24: -2.4M FY25: -958K FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Cost of Revenue Annual

0 7M 14M 21M FY16: 4.1M FY17: 6.2M FY18: 14.4M FY19: 18.6M FY20: 13.4M FY21: 11.4M FY22: 10.7M FY23: 8.9M FY24: 8.5M FY25: 7M FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Operating Cash Flow Annual

-10M -5M 0 5M 10M 15M FY16: -2.1M FY17: 3.6M FY18: 12.6M FY19: -2.2M FY20: -7.3M FY21: -7.5M FY22: -1.9M FY23: 2.3M FY24: -861K FY25: -407K FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Free Cash Flow Annual

-12M -8M -4M 0 4M 8M 12M FY16: -2.1M FY17: 3.2M FY18: 11.7M FY19: -3.4M FY20: -8.4M FY21: -7.5M FY22: -1.9M FY23: 2.3M FY24: -879K FY25: -516K FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 70M 140M 210M FY15: 35.1M FY17: 80.4M FY18: 114.5M FY19: 97.9M FY20: 99.9M FY21: 107.8M FY22: 138M FY23: 154M FY24: 175.6M FY25: 184.3M FY15 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.45 -0.30 -0.15 0.00 0.15 0.30 0.45 Q3 '16: -0.30 Q4 '16: -0.27 Q1 '17: -0.30 Q2 '17: -0.27 Q3 '17: -0.24 Q4 '17: -0.06 Q1 '18: 0.01 Q2 '18: 0.05 Q3 '18: 0.09 Q4 '18: 0.10 Q1 '19: -0.01 Q2 '19: -0.03 Q3 '19: -0.08 Q4 '19: -0.18 Q1 '20: -0.13 Q2 '20: -0.19 Q3 '20: -0.20 Q4 '20: -0.22 Q1 '21: -0.20 Q2 '21: -0.18 Q3 '21: -0.15 Q4 '21: -0.14 Q1 '22: -0.13 Q2 '22: -0.13 Q3 '22: -0.14 Q4 '22: -0.08 Q1 '23: -0.02 Q2 '23: -0.00 Q3 '23: 0.01 Q4 '23: 0.02 Q1 '24: -0.02 Q2 '24: -0.01 Q3 '24: -0.01 Q4 '24: 0.00 Q1 '25: 0.00 Q2 '25: 0.00 Q3 '25: 0.00 Q4 '25: -0.01 Q1 '26: -0.01 Q2 '26: -0.01 Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.